TXN and cancer: The literature exclusively reports that knockout or knockdown of a redoxin, either a peroxiredoxin or a thioredoxin, inhibits cancer cell proliferation [64,65,66,67] and that overexpression protects against various types of cellular stressors [68,69,70,71] and promotes cancer cell growth or drug resistance [72,73,74].